Study reveals high-resolution view of Zika viral life cycle within infected cells

NewsGuard 100/100 Score

New research reveals a high-resolution view of the Zika viral life cycle within infected cells and shows dramatic changes in the cell's architecture throughout the infection process. This novel perspective may lead to the development of new vaccines and treatments.

Zika virus emerged as a public health threat in the western hemisphere in 2015. Infection is associated with severe symptoms in pregnant women and immunocompromised adults, including microcephaly of the developing fetus, visual impairment and development of the autoimmune disease, Guillain-Barré. To survive and produce new copies, Zika virus takes control over the cells it infects. These changes provide protection against host defenses and commandeer the resources of the cell.

In this study, researchers from Boston University School of Medicine (BUSM) compared two groups of mammalian cells in tissue culture. The first group was infected with Zika virus and the second, control group, was not infected. Using light microscopy they observed structural changes at the cell level. Using electron microscopy, they detected more detailed information within the cells and were able produce a three-dimensional structure of the cell's interior. The structural changes induced in Zika virus-infected cells were compared to the uninfected cells.

"After infection of mammalian cells with Zika virus, we show extensive changes in the cell's architecture that are caused by specific stages in the viral life cycle: replication of the virus' genetic material within a protected harbor/bubble-like region, packaging of this material inside a protective capsid shell and finally, exit of the infectious virus from the cell," explained corresponding author Esther Bullitt, PhD, associate professor of physiology and biophysics at BUSM.

According to Bullitt, the findings allow for comparison to virus-induced structures produced when cells are infected with related viruses such as Dengue or West Nile virus. "Based on this new knowledge, potential therapeutics can be developed that prevent the virus from making these changes within the cell, thereby preventing spread of the Zika virus infection. The similarity of changes seen in cells infected with Zika virus or with Dengue virus supports the idea that antiviral drugs could be developed that target both viruses," she said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 booster enhances virus neutralizing antibodies in breast milk, new study reveals